Prokarium
Prokarium is a London-based biotech company focused on developing vaccines and immunotherapies based on engineering biology.
Prokarium has raised €33M across 2 funding rounds from 1 investor, most recently a round in Feb 2023. Based in London, UK; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€33M
€33,046,023
Funding rounds
2
Investors
1
distinct backers
Active since
2019-10
latest 2023-02
Funding by year
EUR raised per yearProkarium — funding by year — interactive chart.
Data table
| Prokarium — funding by year | |
|---|---|
| 2019 | €5.2M |
| 2023 | €28M |
Signals
Medium confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Past typical raise window
- ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-02-09 | Other | €28M | — | View deal → |
| 2019-10-01 | Other | €5.2M | Wellcome Trust | View deal → |
Investors
1Related news
- Prokarium Raises $30M in Fundingfinsmes.com · 2023-02
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData